Pairing computational design with data analytics, the Scientific Computing Research Unit at the University of Cape Town researches and develops practical solutions for treating respiratory infections and cancer more effectively.
Led by computational scientist Professor Kevin J. Naidoo, the South African Research Chair in Scientific Computing, the dynamic and interdisciplinary research unit is driven by the need to equip healthcare providers in Africa with the cutting-edge technologies needed to make affordable and accessible care possible.
"South Africa needs to reduce dependence on imported medicines. We need to have the capacity and capability to design and develop diagnostics and therapeutics to strengthen health systems and economies and make access to care affordable."
- Professor Kevin J. Naidoo, SCRU Director and South African Research Chair in Scientific Computing
Discovering Innovative Healthcare Solutions
Situated in the Department of Chemistry at UCT, one of the world’s leading universities and the top university in Africa, and traversing the faculties of science, engineering, and medicine, the SCRU is well-positioned to lead interdisciplinary innovative research, translate discoveries into clinical solutions, and share these with the South African healthcare sector.
With its own glycobiomedical lab, links to Groote Schuur Hospital and the Red Cross Children’s Hospital, and a local and international network of experts from industry, government, and medical research, the SCRU is advancing the tools and methods needed for inventing drugs and diagnostics for priority health concerns, increasing the number of super-specialists working on the continent, and strengthening local drug design.
Our mantra of “science through computing” guides us as we work for an Africa that is more than capable of providing care for all its citizens.
An Africa where healthcare providers are equipped with cutting edge technologies that enable equitable and accessible care.
We design novel therapeutics and diagnostics for the global healthcare sector, to support effective, personalised treatment of priority health conditions.
Our Facilities and Services
Our approach to addressing Africa's lack of affordable healthcare technology is to design solutions informed by locally developed advanced computational models. To date, we have had:
5 candidate drugs in development
2 patents for disease therapeutics and diagnostics
5 software packages produced
62 trained translation scientists
R12 million invested in cancer and therapeutic research to date